Cited by 145Adrenal and Paraganglionic TumorsRenal cell carcinoma treatmentAdrenal Hormones and Disorders

The Cleveland Clinic experience with adrenal cortical carcinoma

Bodie, Barry, Novick, Andrew C., Pontes, J. Edson, Straffon, Ralph A., Montie, James E., Babiak, Theresa, Sheeler, Leslie, Schumacher, Peter·1989·Journal of Urology

Abstract

Between 1936 and 1987, 82 patients with adrenal cortical carcinoma were seen at our clinic. Of these patients 49 (72 per cent) have been seen during the last 25 years. A total of 40 patients (48.8 per cent) presented with a hormonally functional tumor and 42 (51.2 per cent) had a nonfunctional tumor. Forty patients (48.8 per cent) presented with localized disease, 12 (14.6 per cent) with regional disease and 30 (36.6 per cent) with distant metastases. Complete surgical removal of all gross tumor was achieved in 49 patients. Over-all 3 and 5-year patient survival rates in this series were 37.5 and 25.1 per cent, respectively. Survival was significantly improved (43.9 per cent at 5 years, p equals 0.0001) in patients with localized disease that was completely removed surgically; postoperative adjuvant therapy with op'-DDD was of no benefit in these patients. Survival in patients with metastatic disease was poor and was not improved by treatment with op'-DDD, cytotoxic chemotherapy or radiation therapy.

Integrity signals

Registry

Crossref · 10.1016/s0022-5347(17)40734-8

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Three other studies found radiotherapy ineffective based on experiences in 2, 3, and 5 patients, respectively.

    “Three other studies found radiotherapy to be ineffective on the basis of experiences in 2, 3, and 5 patients, respectively (275, 340, 341).”

    From Adrenocortical carcinoma (2014) · cites this paper as [340]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bodie, B., Novick, A. C., Pontes, J. E., Straffon, R. A., Montie, J. E., Babiak, T., Sheeler, L., & Schumacher, P.
Affiliations
Cleveland Clinic (US)
Venue
Journal of Urology
Published
1989-02
Volume
141
Issue
2
Pages
257-260
ISSN
  • 0022-5347 (ISSN-L)
  • 1527-3792
OpenAlex
W2415859171
Cited by
145
References
20
Citations by year
2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 4 · 2016: 3 · 2015: 2 · 2014: 5 · 2013: 1 · 2012: 6
FWCI
3.25
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Urology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Renal cell carcinoma treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
adrenocortical carcinoma, functional adrenal tumors, metastatic disease, surgical resection, adjuvant therapy, cytotoxic chemotherapy, radiotherapy, survival rate
MeSH terms
Actuarial Analysis, Adrenal Cortex Neoplasms, Adrenalectomy, Adult, Carcinoma, Child, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Male, Mitotane, Ohio, Prognosis, Time Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review